Unique ID issued by UMIN | UMIN000023451 |
---|---|
Receipt number | R000027022 |
Scientific Title | Efficacy and safety of greenpropolis against prostate cancer with biochemical recurrence after radical prostatectomy |
Date of disclosure of the study information | 2016/10/01 |
Last modified on | 2021/06/15 17:53:34 |
Efficacy and safety of greenpropolis against prostate cancer with biochemical recurrence after radical prostatectomy
Clinical trial of greenpropolis against prostate cancer
Efficacy and safety of greenpropolis against prostate cancer with biochemical recurrence after radical prostatectomy
Clinical trial of greenpropolis against prostate cancer
Japan |
Prostate cancer
Urology |
Malignancy
NO
To evaluate efficacy and safety of greenpropolis against prostate cancer with biochemical recurrence after radical prostatectomy.
Safety,Efficacy
Exploratory
Not applicable
PSA response rate
PSA response duration
time to PSA progression
PSA slope before and after administration of propolis
Changes of serum testosterone level
IHC of AKR1C3, AR, and ERG of prostatectomy specimens
QOL
Proportion of adverse events
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Food |
Oral administration of three soft capsules of greenpropolis between or before meals three times a day for 6 months
18 | years-old | <= |
85 | years-old | > |
Male
Adults younger than 85 years, histologically confirmed adenocarcinoma of the prostate cancer with PSA recurrence (PSA>= 0.2 ng/ml, 2 rising PSA tests with >= at least 2-week interval between each determination ) after radical prostatectomy including patients after salvage radiation therapy to prostatic bed; no prior or present evidence of metastatic disease; ECOG 0~2; no surgery or radiation allowed within 4 weeks before day 1.
Previously treated or currently be receiving hormonal therapy with the intent to treat prostate cancer (surgical castration or other hormonal manipulation, e.g. GnRH agonists or antagonists, anti-androgens or estrogens); Evidence of administration of greenpropolis or other alternative therapies within 3 months before day 1. History of allergy against honey, a coniferous tree, a poplar, Peru balsam, and salicylic acid; History of atopic dermatitis, chronic recurrent eczema, and asthma.
40
1st name | Osamu |
Middle name | |
Last name | Ogawa |
Kyoto University Graduate School of Medicine
Urology
6068507
54 Kawaharacho Shogoin Sakyoku Kyoto
075-751-3337
ogawao@kuhp.kyoto-u.ac.jp
1st name | Takahiro |
Middle name | |
Last name | Inoue |
Kyoto University Graduate School of Medicine
Urology
6068507
54 Kawaharacho Shogoin Sakyoku Kyoto
075-751-3337
takahi@kuhp.kyoto-u.ac.jp
Kyoto University Graduate School of Medicine
Kyoto University Graduate School of Medicine
Japanese Governmental office
Kyoto University Graduate School and Faculty of Medicine and Kyot University Hospital Ethics Committe
Konoe Yoshida Sakyoku Kyoto Japan
0757534642
ethcom@kuhp.kyoto-u.ac.jp
NO
2016 | Year | 10 | Month | 01 | Day |
Unpublished
No longer recruiting
2016 | Year | 08 | Month | 02 | Day |
2016 | Year | 09 | Month | 27 | Day |
2016 | Year | 11 | Month | 01 | Day |
2020 | Year | 03 | Month | 31 | Day |
2016 | Year | 08 | Month | 02 | Day |
2021 | Year | 06 | Month | 15 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027022
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |